Figure 5.

Data from the ERA (Early Rheumatoid Arthritis) trial showing the superiority of etanercept over methotrexate, as determined by improvements in erosion and Sharp scores, but not joint-space narrowing score at 2 years. Adapted, with permission, from John Wiley & Sons, Inc. [15].